+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID05675735

Improving Methadone Take-Home Dosing to Increase Retention in Opioid Treatment A Stepped-Wedge Trial Testing Clinic-Level Changes in Opioid Treatment Programs

Led by NYU Langone Health · Updated on 2026-08-12

318

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a clinic-level multidimensional intervention designed to improve clinical decision making, reduce regulatory confusion, alleviate legal and financial concerns, and increase take-home dosing THD of methadone in opioid treatment programs OTPs. This study focuses on adults with opioid use disorder OUD and aims to address disparities in methadone treatment access and retention, especially among BlackAfrican American and Latinx populations. The intervention is tested through a stepped-wedge randomized controlled trial involving 36 OTPs to compare the new approach with usual treatment practices. The intervention includes specific dashboards derived from state databases to support OTP staff in applying regulatory flexibility for methadone THD. Over five years, the trial enrolls OTPs in six cohorts, each receiving a six-month clinic-level intervention at staggered times. The study spans data collection and intervention phases, aiming to increase THD uptake by addressing staff knowledge gaps, training needs, and organizational beliefs. The project is a collaborative effort involving several academic institutions and state addiction services. Participants include clinic staff from selected OTPs and patients aged 18 or older who have received take-home methadone for at least 30 days. The study measures changes in 7-, 14-, and 28-day THD prescriptions, retention in care, emergency department visits, hospitalizations, and all-cause mortality before and after the intervention. Data is collected through state administrative databases and qualitative interviews, with the trial continuing through August 2027 to evaluate the interventions effects on care retention and safety outcomes.

CONDITIONS

Brief Title

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Research Team

C

Charles Neighbors, PhD

B

Beth Knopf, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here